These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 21419205)
1. Development of interferon alpha-2b microspheres with constant release. Li Z; Li L; Liu Y; Zhang H; Li X; Luo F; Mei X Int J Pharm; 2011 May; 410(1-2):48-53. PubMed ID: 21419205 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of recombinant human interferon-alpha-2b poly(lactic-co-glycolic acid) microspheres in rats. Yang F; Shu YJ; Yang YQ; Song FL; Pan YF; Long XY; Chen G; Zhang YM J Microencapsul; 2011; 28(6):483-9. PubMed ID: 21718088 [TBL] [Abstract][Full Text] [Related]
3. Sustained-release protamine sulphate-impregnated microspheres may reduce the frequent administration of recombinant interferon α-2b in ovarian cancer: in-vitro characterization. Gulia M; Rai S; Jain UK; Katare OP; Katyal A; Madan J Anticancer Drugs; 2014 Jan; 25(1):63-71. PubMed ID: 24052106 [TBL] [Abstract][Full Text] [Related]
4. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S; Faraj J; DeLuca P Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159 [TBL] [Abstract][Full Text] [Related]
5. Multivesicular liposome formulations for the sustained delivery of interferon alpha-2b. Qiu J; Wei XH; Geng F; Liu R; Zhang JW; Xu YH Acta Pharmacol Sin; 2005 Nov; 26(11):1395-401. PubMed ID: 16225764 [TBL] [Abstract][Full Text] [Related]
6. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method. Kang J; Wu F; Cai Y; Xu M; He M; Yuan W Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681 [TBL] [Abstract][Full Text] [Related]
7. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900 [TBL] [Abstract][Full Text] [Related]
9. Encapsulation, pharmacokinetics and tissue distribution of interferon α-2b liposomes after intramuscular injection to rats. Li H; Yang L; Cheng G; Wei HY; Zeng Q Arch Pharm Res; 2011 Jun; 34(6):941-8. PubMed ID: 21725815 [TBL] [Abstract][Full Text] [Related]
10. Zinc-alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying. Möbus K; Siepmann J; Bodmeier R Eur J Pharm Biopharm; 2012 May; 81(1):121-30. PubMed ID: 22342605 [TBL] [Abstract][Full Text] [Related]
11. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
12. Long-term release of bioactive interferon-alpha from PLGA-chitosan microparticles: in vitro and in vivo studies. Fleitas-Salazar N; Lamazares E; Pedroso-Santana S; Kappes T; Pérez-Alonso A; Hidalgo Á; Altamirano C; Sánchez O; Fernández K; Toledo JR Biomater Adv; 2022 Dec; 143():213167. PubMed ID: 36356469 [TBL] [Abstract][Full Text] [Related]
13. Effect of excipients on the encapsulation efficiency and release of human growth hormone from dextran microspheres. Vlugt-Wensink KD; Meijer YJ; van Steenbergen MJ; Verrijk R; Jiskoot W; Crommelin DJ; Hennink WE Eur J Pharm Biopharm; 2007 Nov; 67(3):589-96. PubMed ID: 17540550 [TBL] [Abstract][Full Text] [Related]
14. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581 [TBL] [Abstract][Full Text] [Related]
15. PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis. Hinds KD; Campbell KM; Holland KM; Lewis DH; Piché CA; Schmidt PG J Control Release; 2005 Jun; 104(3):447-60. PubMed ID: 15911045 [TBL] [Abstract][Full Text] [Related]
16. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation. Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858 [TBL] [Abstract][Full Text] [Related]
17. Recombinant interferon-alpha2b poly(lactic-co-glycolic acid) microspheres: pharmacokinetics-pharmacodynamics study in rhesus monkeys following intramuscular administration. Zhang YM; Yang F; Yang YQ; Song FL; Xu AL Acta Pharmacol Sin; 2008 Nov; 29(11):1370-5. PubMed ID: 18954532 [TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Doan TV; Couet W; Olivier JC Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123 [TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of once-a-day injectable microspheres of interferon alpha in rats. Yoshikawa Y; Komuta Y; Nishihara T; Itoh Y; Yoshikawa H; Takada K J Drug Target; 1999; 6(6):449-61. PubMed ID: 10937290 [TBL] [Abstract][Full Text] [Related]
20. Construction and in vivo Liu H; Zhu J; Bao P; Ding Y; Shen Y; Webster TJ; Xu Y Int J Nanomedicine; 2019; 14():5339-5353. PubMed ID: 31409991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]